WO2023004608 - L-ERGOTHIONEINE AND THERAPEUTIC USES THEREOF
National phase entry:
Publication Number
WO/2023/004608
Publication Date
02.02.2023
International Application No.
PCT/CN2021/108809
International Filing Date
28.07.2021
Title **
[English]
L-ERGOTHIONEINE AND THERAPEUTIC USES THEREOF
[French]
L-ERGOTHIONÉINE ET SES UTILISATIONS THÉRAPEUTIQUES
Applicants **
NANJING NUTRABUILDING BIO-TECH CO., LTD.
No. 270 Jiqingmen Street, Suning Huigu Building E6, Room 1805
Nanjing, Jiangsu 210017, CN
Inventors
WANG, Mingru
No. 270 Jiqingmen Street, Suning Huigu, Building E6, Room 1805
Nanjing, Jiangsu 210017, CN
YI, Ronghua
No. 270 Jiqingmen Street, Suning Huigu, Building E6, Room 1805
Nanjing, Jiangsu 210017, CN
WELLS, Shawn
2560 King Arthur Blvd. Suite 124-74
Lewisville, Texas 75056, US
LIAO, Kylin
No. 270 Jiqingmen Street, Suning Huigu, Building E6, Room 1805
Nanjing, Jiangsu 210017, CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
CNIPA
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1273 | |
| EPO | Filing, Examination | 9891 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 482 | |
| USA | Filing, Examination | 4510 |
Total: 16747 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
L-ergothioneine, novel forms of L-ergothioneine, and therapeutic uses thereof, particularly for immune support and nutrient supplementation.[French]
L'invention a trait à la L-ergothionéine, de nouvelles formes de L-ergothionéine, et leurs utilisations thérapeutiques, en particulier pour le support immunitaire et la supplémentation nutritionnelle.